Dealbreaker on MSN
Liquid biopsy firm Freenome finds a way to the public markets via $330M SPAC merger
Freenome’s SPAC merger agreement comes as the liquid biopsy developer prepares for potential 2026 commercialization of ...
We present LFM2-Audio-1.5B, Liquid AI's first end-to-end audio foundation model. Built with low-latency in mind, the lightweight LFM2 backbone enables real time speech-to-speech conversations without ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback